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Genome  segments  of the foot-and-mouth disease  virus 
isolates 01Lombardy and 03Venezuela that encode, 
among other  products, capsid  protein  VP1 were ampli- 
fied using PCR, and the products were cloned and 
sequenced. The alignment  of up to 11 03-specific 
sequences  revealed six silent nucleotide  changes as well 
as  six changes  that  cause  amino  acid  substitutions in 
capsid protein VP1 at positions 45, 83, 141, 145, 170 and 
178. The heterogeneity of three 01-specific sequences 
consisted   of  seven  silent  exchanges   and  amino   acid 
changes at positions  85 and 134 on VPl. Amplification, 
subcloning  and sequencing  of cloned 03-specific cDNA 
was performed to examine the nature of the sequence 
heterogeneity.  As no difference was found among five 
subcloned  sequences,  we conclude  that  the  Taq poly- 
merase copied the DNA correctly. The sequence 
heterogeneity observed  with both  virus isolates  is, 
therefore,  consistent  with the quasispecies structure  of 
foot-and-mouth disease virus. Furthermore, amino acid 
changes  at  a  number  of sites  have  been  found  to  be 
involved in the formation  or modulation of neutralizing 
epitopes.  The novel aspect of this study is the ability to 
estimate,  by cloning  of PCR  products,  the  number  of 
virus isotypes,  possibly varying in antigenicity,  that  are 
able  to  co-propagate. Seven  isotypes  of  03Venezuela 
were identified.  Some are of particular interest  because 
they exhibit a change at VP1 codon  145 that causes the 
replacement  of arginine, possibly essential for virus 
attachment to cells, by isoleucine. 
 
 
Foot-and-mouth disease virus (FMDV)  consists of 60 
copies each of the four capsid proteins VPl  to VP4 and 
one  positive-sense  single-stranded  genomic  RNA 
(Rueckert,  1990). FMDV  is extremely variable in 
antigenicity, and consequently seven serotypes are 
recognized. Each serotype comprises a number of isolates 
that differ to a varying extent from each other in 
immunological reactivity  (Pereira,  1977). According  to 
the  quasispecies  structure of FMDV  (Domingo  et  al., 
1992), each virus isolate consists of several genetic and 
antigenic  variants. 
From a practical point of view it is important to know 
about   the  antigenic  variability  of  an  FMDV   isolate, 
because some variants may be better able to resist host 
defences than others.  Antigenie variation  is frequently 
observed at those parts ofVPl which are involved in the 
formation of neutralizing  epitopes  (residues  133 to 160 
and the C terminus; Strohmaier et al., 1982; Bittle et al., 
1982), orthat influence steric configuration  (residues 40 
to 60; Parry  et al., 1990). The dominance  of VP1 in the 
structure   of  the  virus  surface  (Acharya   et  al.,  1989; 
Logan  et  al.,  1993)  explains  its  importance  in  anti- 
genicity. 
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If present, it may be possible to detect sequence 
heterogeneity among copassaged FMDV  by amplifying 
capsid protein-coding  parts of the genome using PCR 
(Arnheim & Erlich, 1992), followed by molecular cloning 
of  the  reaction  products  and  alignment  of  their  sequ- 
ences. 
The suitability of this strategy was examined using the 
FMDV   isolates  01Lombardy /1946  and  Ü3Venezuelaj 
1951. One kb of each virusgenomewas analysed which 
encodes half ofVP3, VP1 and the peptide 2A. As VP1 is 
the most variable of the FMDV capsid proteins 
(Palmenberg, 1989), there was a high probability  of 
detecting  heterogeneity  in the VPI-coding sequence. 
Monolayer  BHK21 cells (Stoker & Macpherson, 1964) 
in  roller  tubes  (6 x 35 cm)  were  infected  either   with 
FMDV    01Lombardy /1946   (28th   passage)   or   with 
FMDV  03Venezuelaj1951  (ninth  and  11th  passages). 
Ten times-passaged  03Venezuela  was purified from  the 
supernatant of infected cells as described by Strohmaier 
&  Adam  (1976). Ten mg virus  was  obtained,   by CsCl 
gradient   centrifugation,  from  which  1 mg  RNA   was 
extracted  as described  by Marquardt &  Adam  (1990). 
Cells   infected   with   03Venezuela   (which   bad   been 
passaged 11 times) or with 01Lombardy were lysed when 
early  cytopathic  effect became  visible, and  total  RNA 
was  extracted   by  the  acid  guanidinium   thiocyanate- 
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Fig. l. The 03Venezuela (03V)  consensus sequence is shown in the top 
line. Aligned to it are the sequences of 01Kaufbenren (0l K), numbered 
according   to  the  UWGCG  data   file, and  of  01Lombardy  (OlL). 
Dots indicate sequence identity, lower case letters silent sequence 
differences, and  upper  case letters  codon  changes.  >, Beginnings of 
the  VPl-  and  2A-encoding  regions.  Positions  causing  codon  switch 
among    copassaged    03Venezuela   or   01Lombardy    are   indicated 
by  #  above  and   below  the  respective  sequence,  silent  differences 
by   * Underlining    indicates   sequences   used   to   bind   sequencing 
primers. 
chloroform-phenol  method   (Chomczynski   &  Sacchi, 
1987). 
One Jlg RNA  extracted  from virus particles, or 20 11g 
RNA extracted  from FMDV-infected cells, was hybrid- 
ized with the antisense oligodeoxynucleotide 
GAAGGGCCCAGGGTTGGACTC, and was then 
incubated  with retroviral  reverse transcriptase as recom- 
mended  by  the  supplier  of  the  enzyme  (Stratagene). 
Two 111  of  the  reaction  volume  and  50 ng each  of  the 
antisense primer and the positive sense oligodeoxy- 
nucleotide  CACCATCAACCTGCACTTCA (positions 
3572   to   3592   and   2548   to   2567   on   the   FMDV 
01Kaufbeuren  genome  map;  Forss  et  al.,  1984; 
UWGCG  data    file  APH01KL. VIRAL)    were   then 
subjected to the PCR, performed as recommended  by the 
supplier of the Taq polymerase (Promega),  in a Bio-med 
Thermocycler  60. Thirty  cycles of polymerization, con- 
sisting of denaturation for 1 min at 93 °C, annealing  for 
2 min at  55 oc and  extension  for  5 min at  72 °C, were 
performed.   The   volume   of  analytical   reactions   was 
100 Jll, that  of preparative  reactions  1 ml. Occasionally, 
10  to  20 ng  of  the  PCR   product   was  amplified   by 
secondary   PCR.   The   yield   of   PCR   products    was 
estimated  by comparing reaction aliquots  and the DNA 
ladder (Gibco BRL) in agarose gel electrophoresis, 
followed by ethidium  bromide  staining. 
Plasmid  pSPT18 (Boehringer  Mannheim)  was linear- 
ized  at  its  multiple  cloning  site  by  restriction  enzyme 
Smal and dephosphory1ated. PCR products were first 
treated   with  Klenow  enzyme  and  T4  polynucleotide 
kinase and then Iigated with the vector in a molar  ratio 
of 3: I according to standard procedures (Maniatis et al., 
1982).  Escherichia coli HB101  cells  were  transformed 
with the ligation products and seeded on LB agar dishes. 
Plasmid DNA was extracted from ampicillin-resistant 
clones and  analysed  for  inserts  by agarose  gel electro- 
phoresis. 
The FMDV  type 0 specificity ofthe cloned cDNA was 
confirmed by sequencing reactions, performed according 
to the protocol  recommended by the supplier ofthe assay 
kit   (Pharmacia-LKB).   The   SP6   and   T7   promoter 
primers,  as well as the  type  0 FMDV-specific  primers 
mentioned  above and indicated in Fig. 1 were used. The 
FMDV-specific  primers  were synthesized with an auto- 
mated  DNA  synthesizer (Biosearch 8700, Milligen). 
Two  families  of  03Venezuela-specific  cDNA  clones 
were obtained.  The  first originated  from  tenfold- 
passaged,  purified  virus  by  primary  (family  1. 1) and 
secondary (family 1 . 2) PCR, the second from virus at its 
12th passage by single PCR (family 2). Alignment of 
sequences obtained  from the first clones revealed both 
changed codons and silent sequence differences. There- 
fore, further  cDNA  clones were sequenced. Aligning six 
sequences,  the differences were found  to  be distributed 
 
 
 
Table 1. Location, nature and frequency of sequence 
di.fferences among cloned 03 Venezuela-specific PCR 
products 
 
Sequence family 
Nucleotide 
position*  1.1  1.2  2 
 
2890 NDt c, u,  c, u, 
3032 (045) ND A,  Aa Gs 
3040 ND a, a, g, 
3109 ND a, a, g, 
3146 (083) ND A,  A2  G6 
3265 ND g, u,  g, 
3321 (141) A, A 1 U 1 A1 U 6 
3333 (145) u, u, G" u" 
3403 c, u,  c,  c. 
3408 (170) c, c, u, c, 
3432 (178) A,  A,  A6  G, 
3433 u,  c,  c1 u5 
 
*  Nucleotides are numbered according to the FMDV 01Kaufbeuren 
sequence. Positions ofheterogeneous amino acids on VP1 are shown in 
parentheses,  and  the crucia1 nucleotides  are indicated  by upper  case 
letters. Silent sequence differences are indicated  by lower case letters. 
The  number  suffixed to  each  nucleotide  indicates  the  frequency  of 
determination. 
t ND, Not determined. 
was aligned to equivalent  sequences of FMDV  01Kauf- 
beuren,  established  from  cloned  cDNA   (Forss  et  al., 
1984), and FMDV  01Lombardy, established either by 
direct RNA sequencing (Krebs et al., 1991) or by 
sequencing   of  cloned  PCR   products.   The  alignment 
showed that 03Venezuela differed in the sequence under 
investigation  from  both  other  FMDV  isolates  by more 
than  13%. 
The results presented here were obtained  by reverse 
transcription of FMDV  RNA and subsequent  Taq- 
dependent  DNA  polymerization. Together,  both re- 
actions can produce nucleotide sequence errors at a rate 
of about  w-4, which is equivalent  to the rate observed 
during FMDV  RNA  replication  (Domingo  et al., 1992). 
To estimate the error rate in the DNA amplification 
reaction,  one sample  of cloned  cDNA  of 03Venezuela 
was  subjected  to  PCR,  and  the  products  were cloned 
following ligation into the vector pBR322, linearized by 
restriction  enzyme Seal. The PCR product  sequences of 
five tetracycline-resistant clones were determined  be- 
tween nucleotide  positions  3000 and 3380. No sequence 
deviation  could  be detected (data  not shown),  although 
this   region   exhibited   seven   differences   when   virus 
_ ß E <tB ß F   !Q!._ genomes served as templates for cDNA  synthesis. It was 
111 FTGPTDAKARYMVAYAPPGMDPPNTPEAAAHCIHAEWDTGLNSKFTFSIP 
 
ßH ßi 
concluded   from   these  results  that   the  sequence  het- 
erogeneity  among  cloned  03Venezuela-specific  cDNA 161 YLSAADYAYTASDVAETTNVQGWICLFQITHGKADGDALVVLASAGKDFE 
(Table 1) arose due to genetic heterogeneity  of the virus 
 
211  LRLPVDARTQ 'ffilGESADPVTSTVENYGGETQVQMQHTD; FIMD 
 
l.L <tA !!D .....!.!._ 
41    KVTPKOOINVLDLMQIPGHTLVGALLRASTYYFSDLEIA GVLTWVP 
_g_ lli 91 NGAPEQALDNTTNPTAYHKAPLTRLALPYTAPHRVLATVYNGR?RYSRDV 
v  r ßi 
141  ETNVR_GDLQA.LAHKAAl!.SLPTSFNYGAIKV""TRVTELL RMKRAETYCPRP 
 
191 LLAIHPTEARHKQKivnPVKQT LKLAGDVESNP tB 
Fig. 2. Sequence, sequence variance and  probable  structure  of capsid 
protein VPI ofFMDV 03Venezuela. The amino acid sequence ofVP1 
and  its  neighbours   of  03Venezuela,  deduced  from   the  nucleotide 
sequence (Fig. 1), is presented in the one-letter code and numbered. <X- 
helices and ß-sheets observed  for FMDV  01BFS are indicated  above 
the sequence, as weil as the N-terminal  residue ( >) of the designated 
polypeptides.  Sequence  variation   is indicated  by  two  letters  at  one 
position.  j, Positions of sequence variance observed with 01Lombardy. 
 
 
unevenly. The VP3-coding part differed at only one 
position, whereas the VP1-coding part differed at several 
positions.  Therefore,  the  latter  was analysed  up  to  11 
times using both cDNA  families. 
The alignment  of all 03Venezuela-specific sequences 
showed six silent nucleotide changes as well as six codon 
changes (Table  1). All of the latter  concerned  the VP1- 
coding   region   (Fig.   1, 2).  An   03-specific   consensus 
sequence was assemb1ed, and  the positions of het- 
erogeneaus sequence were marked (Fig. 1). This sequence 
genomes. The finding that  there were six positions  that 
differed either in both sequence families, or were found at 
a different rate in sequence family 2, supports the above 
conclusion. The other six positions where a different 
nucleotide was found only once are less certain indicators 
of heterogeneaus virus genome sequences. They may, 
however,  represent   minor   populations  of  the  quasi- 
specJes. 
Five of the predicted  amino  acid changes are located 
within ß-sheet-connecting loops (Fig. 2), protein domains 
that tolerate amino acid changes more easily than do 
domains  of structural importance. This may be no 
accident, and might perhaps indicate that the virus was 
subjected to some kind of selection pressure while 
circulating  in the field, for instance during  the course of 
persistent  infection  (Gebauer  et al., 1988). Support for 
this hypothesis comes from the fact that sequence 
heterogeneity   of  VP1  has   been  observed   at   similar 
positions  when monoclonal  antibody  escape mutants  of 
the  FMDV   types  A,  C  and  0 have  been  sequenced 
(Thomas et al., 1988; Baxt et al., 1989; Parry et al., 1990; 
Feigelstock et al., 1992). That antigenic variation  occurs 
in  a  single  passage  of  FMDV   has  previously   been 
suggested by the demonstration that virus from different 
plaques of an isolate differed in immunological reactivity 
and  nucleotide sequence (Rowlands  et al., 1983; Mateu 
et al., 1989). 
   
 
 
Table 2. The observed FMDV  03 Venezuelaisotypes 
 
Codon number 
viral receptor  binding site (Fox  et al., 1989). The codon 
for  Ile was  found  in  the  genome  of  serially  passaged 
FMDV,  indicating  the infectivity of the corresponding Cloned 
cDNA* 0451 0831 1411 1451 1701  
1.2.08 AAA AAG GAG AUA  GCA  at 
 K K E I A bt 1.2.10 AAA AAG GUG AUA GUA a 
 K K V I V b 2.21 AAA AAG GUG AUA GCA a 
 K K V I A b 2.03 AAA AAG GUG AGA GCA a 
 K K V R A b 2.15 AAA GAG GUG AGA GCA a 
 K E V R A b 2.06 GAA GAG GUG AGA GCA a 
 E E V R A b 2.11 GAA GAG GUG AUA GCA a 
 E E V I A b 
* Digits  before  the  point indicate clone  families, others  the  clone 
designation. 
t a, Codon  sequence_ 
t b,  Encoded amino acid. 
 
Seven isotypes of VPl  of FMDV  03Venezuela could 
be  distinguished   with  regard   to  the  amino   acids  at 
positions  45,  83,  141, 145 and  170 (Table  2).  As  the 
isotypes  differed by up to four  residues, it is likely that 
some  may  also  differ  in  antigenicity.   Further   virus 
isotypes may exist, considering the amino acid change at 
codon  178 on  VPl,  and  speculating  that  VP2  andjor 
VP3 may also exhibit residue changes.  No attempt  was 
made to identify all of the isotypes present in passages 9 
and 11 of 03Venezuela, as the results presented here are 
considered sufficient to demonstrate the coexistence of 
multiple  isotypes.  As  one  virus  genome  template  for 
cDNA  synthesis was extracted  from  purified virus 
particles, it is likely that the various protein isotypes 
assembled correctly  to form virus particles. 
In order to determine whether different isotypes could 
also be identified  by the same method  in other  FMDV 
isolates,  a  genome  fragment  of  FMDV  01Lombardy, 
equivalent tothat of03Venezuela, was amplified by PCR 
and cloned. Three cloned PCR products were sequenced. 
The alignment  to the sequence obtained  by direct RNA 
sequencing   revealed  seven  silent  differences  and   het- 
erogeneaus  codons 85 (encoding either D or Y) and 134 
(C  or   S)  in   the   VP1-coding   region   (Fig.   1).  The 
corresponding amino  acids reside in the loops DE and 
G H.  lt was concluded  that  antigenic  variation  among 
copassaged  FMDV  can  be identified  using the method 
outlined  above,  irrespective  of  the  virus  isolate  under 
investigation,   and   that   the  number   of  variants   thus 
detected depends upon  the amount  of sequence analysis 
performed. 
The frequent  observation  of a codon for Ile instead of 
Arg at position 145 on VP1 ofthe 03Venezuelan genome 
was unexpected, because Arg is thought  to be part of the 
 
genome. Whether virus particles that have Ile at position 
145 on VPl  are infectious is unknown at present. 
The coexistence of isotypes of FMDV  has considerable 
implications   for   the  concept   of  developing   FMDV 
subunit   vaccines  (for   review,  see  Brown,   1990),  as 
isotypes may differ in antigenicity. Immunization with 
antigen   of  a  single  homogeneaus  sequence  may  not 
protect against all accumulated  virus variants that evolve 
in the field. The demonstration of coexisting FMDV 
isotypes by application of the PCR confirms previous 
observations on antigenic  heterogeneity  of plaques  and 
escape mutants of FMDV  and other RNA viruses (see 
citations  given above, and  references therein). 
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